Icon

XPHOZAH (NDA213931)- (EQ 10MG BASE,EQ 20MG BASE,EQ 30MG BASE)

TENAPANOR HYDROCHLORIDE ARDELYX INC
EQ 10MG BASE,EQ 20MG BASE,EQ 30MG BASE
No No
2034-Apr-10 2024-Sep-12
None 2026-Oct-17
None No
XPHOZAH is a sodium hydrogen exchanger 3 (NHE3) inhibitor indicated to reduce serum phosphorus in adults with chronic kidney disease (CKD) on dialysis as add-on therapy in patients who have an inadequate response to phosphate binders or who are intolerant of any dose of phosphate binder therapy .
0 0 0
Total Other Developers None
Drugs with Suitability No
EQ 10MG BASE ** ** - - -
EQ 20MG BASE ** ** - - -
EQ 30MG BASE ** ** - - -
NDA Sales Available Total Generic Sales Available
No 0
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search




Expired
to
Expired
to


Brand Name Generic Name Strength Dosage Route of Administration Innovator ParaIV

Please contact contact@researchdelta.com to get more details.